Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Developing allogeneic chimeric antigen receptor (CAR) -T cell therapies9.99M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States9.27M92.76%
Rest of world724K7.24%